Overview

Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder

Status:
Enrolling by invitation
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compulsive disorder (OCD).
Phase:
Phase 3
Details
Lead Sponsor:
Biohaven Pharmaceuticals, Inc.